Comments
Loading...
Galera Therapeutics (OTC:GRTX) Stock, Earnings Estimates, EPS, And Revenue
Galera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 14
EPS
$-0.070
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Galera Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Galera Therapeutics (GRTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-03-28 | $-0.10 | $-0.35 | 71.4 % |
| Sep 2023 | 2023-11-14 | $-0.33 | $-0.40 | 17.5 % |
| Jun 2023 | 2023-08-14 | $-0.48 | $-0.43 | -11.6 % |
| Mar 2023 | 2023-05-11 | $-0.50 | $-0.38 | -31.6 % |
Galera Therapeutics (GRTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Galera Therapeutics (OTCPK:GRTX) reporting earnings?
Galera Therapeutics (GRTX) is scheduled to report earnings on December 3, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
What were the latest earnings per share (EPS) for Galera Therapeutics (OTCPK:GRTX)?
The Actual EPS was $-0.07, which missed the estimate of $0.00.
What were Galera Therapeutics’s (OTCPK:GRTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.